Profile
Kevin Patrick Lynch worked as a Vice President at Celgene Corp.
from 2011 to 2019.
He also worked as a Medical Director-Oncology at Novartis Pharmaceuticals Australia Pty Ltd.
and as an Executive Director & Chief Medical Officer at Antengene Corp.
Ltd.
in 2021.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/12/2022 | 0 ( -.--% ) | - $ | 30/03/2024 |
Former positions of Kevin Patrick Lynch
| Companies | Position | End |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Chief Tech/Sci/R&D Officer | 15/12/2022 |
| CELGENE | Corporate Officer/Principal | 31/12/2018 |
Novartis Pharmaceuticals Australia Pty Ltd.
 Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Health Technology |
- Stock Market
- Insiders
- Kevin Patrick Lynch
